Back to Search
Start Over
A novel biosignature to assess residual risk in ductal carcinoma in situ (DCIS) patients after standard treatment
- Publication Year :
- 2020
Details
- Database :
- OAIster
- Notes :
- English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1234764577
- Document Type :
- Electronic Resource
- Full Text :
- https://doi.org/10.1200.JCO.2020.38.15_suppl.548